Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...

Welcome to E-Menai

12.5 ambien cr mg and Canadian marketing rights for Cambia from Applied Pharma Research (APR), a Swiss drug delivery and drug development company, in 2005. is a specialty pharmaceutical company focused primarily in the area of cardiology. Acura and King are currently evaluating the FDA's Complete Response Letter, and at this stage believe they can respond to the issues raised without conducting any additional studies. The Acurox Tablets NDA was originally accepted for filing by FDA earlier this year with a priority review classification. King's wholly-owned subsidiary, Alpharma, Inc.

.


NewsA Level

(KPA), a privately-held specialty pharmaceutical company headquartered in Montgomery, AL, announced today that the U. "The approval is the culmination of over three years of effort from our partners at Applied Pharma Research and the internal team at Kowa," said William Maichle, Chief Operating Officer of Kowa Pharmaceuticals America, Inc. APR has signed licensing agreements with pharmaceutical companies in 117 countries worldwide and its sales are almost totally achieved abroad. The Companies plan to meet with the FDA following submission of their response..